Global HMOs Market Growth (Status and Outlook) 2025-2031

March 2025 | 89 pages | ID: G61CBBF0FF15EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global HMOs market size is predicted to grow from US$ 890 million in 2025 to US$ 1800 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.

Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.

HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.

With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.

Market Development Opportunities and Key Drivers:

As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.

Market Risks:

Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.

Market Concentration:

Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.

Downstream Demand Trends:

The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.

Latest Technologies:

The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.

LPI (LP Information)' newest research report, the “HMOs Industry Forecast” looks at past sales and reviews total world HMOs sales in 2024, providing a comprehensive analysis by region and market sector of projected HMOs sales for 2025 through 2031. With HMOs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HMOs industry.

This Insight Report provides a comprehensive analysis of the global HMOs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HMOs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HMOs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HMOs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HMOs.

This report presents a comprehensive overview, market shares, and growth opportunities of HMOs market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Neutral HMOs
  • Acidic HMOs
Segmentation by Application:
  • Food Industry
  • Laboratory Research
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Dupont (Inbiose)
  • DSM (Glycom)
  • Chr. Hansen (Jennewein)
  • BASF
  • FrieslandCampina
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HMOs Market Size (2020-2031)
  2.1.2 HMOs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for HMOs by Country/Region (2020, 2024 & 2031)
2.2 HMOs Segment by Type
  2.2.1 Neutral HMOs
  2.2.2 Acidic HMOs
2.3 HMOs Market Size by Type
  2.3.1 HMOs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global HMOs Market Size Market Share by Type (2020-2025)
2.4 HMOs Segment by Application
  2.4.1 Food Industry
  2.4.2 Laboratory Research
2.5 HMOs Market Size by Application
  2.5.1 HMOs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global HMOs Market Size Market Share by Application (2020-2025)

3 HMOS MARKET SIZE BY PLAYER

3.1 HMOs Market Size Market Share by Player
  3.1.1 Global HMOs Revenue by Player (2020-2025)
  3.1.2 Global HMOs Revenue Market Share by Player (2020-2025)
3.2 Global HMOs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HMOS BY REGION

4.1 HMOs Market Size by Region (2020-2025)
4.2 Global HMOs Annual Revenue by Country/Region (2020-2025)
4.3 Americas HMOs Market Size Growth (2020-2025)
4.4 APAC HMOs Market Size Growth (2020-2025)
4.5 Europe HMOs Market Size Growth (2020-2025)
4.6 Middle East & Africa HMOs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas HMOs Market Size by Country (2020-2025)
5.2 Americas HMOs Market Size by Type (2020-2025)
5.3 Americas HMOs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HMOs Market Size by Region (2020-2025)
6.2 APAC HMOs Market Size by Type (2020-2025)
6.3 APAC HMOs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HMOs Market Size by Country (2020-2025)
7.2 Europe HMOs Market Size by Type (2020-2025)
7.3 Europe HMOs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HMOs by Region (2020-2025)
8.2 Middle East & Africa HMOs Market Size by Type (2020-2025)
8.3 Middle East & Africa HMOs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HMOS MARKET FORECAST

10.1 Global HMOs Forecast by Region (2026-2031)
  10.1.1 Global HMOs Forecast by Region (2026-2031)
  10.1.2 Americas HMOs Forecast
  10.1.3 APAC HMOs Forecast
  10.1.4 Europe HMOs Forecast
  10.1.5 Middle East & Africa HMOs Forecast
10.2 Americas HMOs Forecast by Country (2026-2031)
  10.2.1 United States Market HMOs Forecast
  10.2.2 Canada Market HMOs Forecast
  10.2.3 Mexico Market HMOs Forecast
  10.2.4 Brazil Market HMOs Forecast
10.3 APAC HMOs Forecast by Region (2026-2031)
  10.3.1 China HMOs Market Forecast
  10.3.2 Japan Market HMOs Forecast
  10.3.3 Korea Market HMOs Forecast
  10.3.4 Southeast Asia Market HMOs Forecast
  10.3.5 India Market HMOs Forecast
  10.3.6 Australia Market HMOs Forecast
10.4 Europe HMOs Forecast by Country (2026-2031)
  10.4.1 Germany Market HMOs Forecast
  10.4.2 France Market HMOs Forecast
  10.4.3 UK Market HMOs Forecast
  10.4.4 Italy Market HMOs Forecast
  10.4.5 Russia Market HMOs Forecast
10.5 Middle East & Africa HMOs Forecast by Region (2026-2031)
  10.5.1 Egypt Market HMOs Forecast
  10.5.2 South Africa Market HMOs Forecast
  10.5.3 Israel Market HMOs Forecast
  10.5.4 Turkey Market HMOs Forecast
10.6 Global HMOs Forecast by Type (2026-2031)
10.7 Global HMOs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market HMOs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott HMOs Product Offered
  11.1.3 Abbott HMOs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Dupont (Inbiose)
  11.2.1 Dupont (Inbiose) Company Information
  11.2.2 Dupont (Inbiose) HMOs Product Offered
  11.2.3 Dupont (Inbiose) HMOs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Dupont (Inbiose) Main Business Overview
  11.2.5 Dupont (Inbiose) Latest Developments
11.3 DSM (Glycom)
  11.3.1 DSM (Glycom) Company Information
  11.3.2 DSM (Glycom) HMOs Product Offered
  11.3.3 DSM (Glycom) HMOs Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 DSM (Glycom) Main Business Overview
  11.3.5 DSM (Glycom) Latest Developments
11.4 Chr. Hansen (Jennewein)
  11.4.1 Chr. Hansen (Jennewein) Company Information
  11.4.2 Chr. Hansen (Jennewein) HMOs Product Offered
  11.4.3 Chr. Hansen (Jennewein) HMOs Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Chr. Hansen (Jennewein) Main Business Overview
  11.4.5 Chr. Hansen (Jennewein) Latest Developments
11.5 BASF
  11.5.1 BASF Company Information
  11.5.2 BASF HMOs Product Offered
  11.5.3 BASF HMOs Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 BASF Main Business Overview
  11.5.5 BASF Latest Developments
11.6 FrieslandCampina
  11.6.1 FrieslandCampina Company Information
  11.6.2 FrieslandCampina HMOs Product Offered
  11.6.3 FrieslandCampina HMOs Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 FrieslandCampina Main Business Overview
  11.6.5 FrieslandCampina Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. HMOs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. HMOs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Neutral HMOs
Table 4. Major Players of Acidic HMOs
Table 5. HMOs Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global HMOs Market Size by Type (2020-2025) & ($ millions)
Table 7. Global HMOs Market Size Market Share by Type (2020-2025)
Table 8. HMOs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global HMOs Market Size by Application (2020-2025) & ($ millions)
Table 10. Global HMOs Market Size Market Share by Application (2020-2025)
Table 11. Global HMOs Revenue by Player (2020-2025) & ($ millions)
Table 12. Global HMOs Revenue Market Share by Player (2020-2025)
Table 13. HMOs Key Players Head office and Products Offered
Table 14. HMOs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global HMOs Market Size by Region (2020-2025) & ($ millions)
Table 18. Global HMOs Market Size Market Share by Region (2020-2025)
Table 19. Global HMOs Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global HMOs Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas HMOs Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas HMOs Market Size Market Share by Country (2020-2025)
Table 23. Americas HMOs Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas HMOs Market Size Market Share by Type (2020-2025)
Table 25. Americas HMOs Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas HMOs Market Size Market Share by Application (2020-2025)
Table 27. APAC HMOs Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC HMOs Market Size Market Share by Region (2020-2025)
Table 29. APAC HMOs Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC HMOs Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe HMOs Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe HMOs Market Size Market Share by Country (2020-2025)
Table 33. Europe HMOs Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe HMOs Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa HMOs Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa HMOs Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa HMOs Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of HMOs
Table 39. Key Market Challenges & Risks of HMOs
Table 40. Key Industry Trends of HMOs
Table 41. Global HMOs Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global HMOs Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global HMOs Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global HMOs Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Details, Company Type, HMOs Area Served and Its Competitors
Table 46. Abbott HMOs Product Offered
Table 47. Abbott HMOs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Main Business
Table 49. Abbott Latest Developments
Table 50. Dupont (Inbiose) Details, Company Type, HMOs Area Served and Its Competitors
Table 51. Dupont (Inbiose) HMOs Product Offered
Table 52. Dupont (Inbiose) HMOs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Dupont (Inbiose) Main Business
Table 54. Dupont (Inbiose) Latest Developments
Table 55. DSM (Glycom) Details, Company Type, HMOs Area Served and Its Competitors
Table 56. DSM (Glycom) HMOs Product Offered
Table 57. DSM (Glycom) HMOs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. DSM (Glycom) Main Business
Table 59. DSM (Glycom) Latest Developments
Table 60. Chr. Hansen (Jennewein) Details, Company Type, HMOs Area Served and Its Competitors
Table 61. Chr. Hansen (Jennewein) HMOs Product Offered
Table 62. Chr. Hansen (Jennewein) HMOs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chr. Hansen (Jennewein) Main Business
Table 64. Chr. Hansen (Jennewein) Latest Developments
Table 65. BASF Details, Company Type, HMOs Area Served and Its Competitors
Table 66. BASF HMOs Product Offered
Table 67. BASF HMOs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. BASF Main Business
Table 69. BASF Latest Developments
Table 70. FrieslandCampina Details, Company Type, HMOs Area Served and Its Competitors
Table 71. FrieslandCampina HMOs Product Offered
Table 72. FrieslandCampina HMOs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. FrieslandCampina Main Business
Table 74. FrieslandCampina Latest Developments



LIST OF FIGURES

Figure 1. HMOs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HMOs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. HMOs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. HMOs Sales Market Share by Country/Region (2024)
Figure 8. HMOs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global HMOs Market Size Market Share by Type in 2024
Figure 10. HMOs in Food Industry
Figure 11. Global HMOs Market: Food Industry (2020-2025) & ($ millions)
Figure 12. HMOs in Laboratory Research
Figure 13. Global HMOs Market: Laboratory Research (2020-2025) & ($ millions)
Figure 14. Global HMOs Market Size Market Share by Application in 2024
Figure 15. Global HMOs Revenue Market Share by Player in 2024
Figure 16. Global HMOs Market Size Market Share by Region (2020-2025)
Figure 17. Americas HMOs Market Size 2020-2025 ($ millions)
Figure 18. APAC HMOs Market Size 2020-2025 ($ millions)
Figure 19. Europe HMOs Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa HMOs Market Size 2020-2025 ($ millions)
Figure 21. Americas HMOs Value Market Share by Country in 2024
Figure 22. United States HMOs Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada HMOs Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico HMOs Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil HMOs Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC HMOs Market Size Market Share by Region in 2024
Figure 27. APAC HMOs Market Size Market Share by Type (2020-2025)
Figure 28. APAC HMOs Market Size Market Share by Application (2020-2025)
Figure 29. China HMOs Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan HMOs Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea HMOs Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia HMOs Market Size Growth 2020-2025 ($ millions)
Figure 33. India HMOs Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia HMOs Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe HMOs Market Size Market Share by Country in 2024
Figure 36. Europe HMOs Market Size Market Share by Type (2020-2025)
Figure 37. Europe HMOs Market Size Market Share by Application (2020-2025)
Figure 38. Germany HMOs Market Size Growth 2020-2025 ($ millions)
Figure 39. France HMOs Market Size Growth 2020-2025 ($ millions)
Figure 40. UK HMOs Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy HMOs Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia HMOs Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa HMOs Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa HMOs Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa HMOs Market Size Market Share by Application (2020-2025)
Figure 46. Egypt HMOs Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa HMOs Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel HMOs Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey HMOs Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries HMOs Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas HMOs Market Size 2026-2031 ($ millions)
Figure 52. APAC HMOs Market Size 2026-2031 ($ millions)
Figure 53. Europe HMOs Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa HMOs Market Size 2026-2031 ($ millions)
Figure 55. United States HMOs Market Size 2026-2031 ($ millions)
Figure 56. Canada HMOs Market Size 2026-2031 ($ millions)
Figure 57. Mexico HMOs Market Size 2026-2031 ($ millions)
Figure 58. Brazil HMOs Market Size 2026-2031 ($ millions)
Figure 59. China HMOs Market Size 2026-2031 ($ millions)
Figure 60. Japan HMOs Market Size 2026-2031 ($ millions)
Figure 61. Korea HMOs Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia HMOs Market Size 2026-2031 ($ millions)
Figure 63. India HMOs Market Size 2026-2031 ($ millions)
Figure 64. Australia HMOs Market Size 2026-2031 ($ millions)
Figure 65. Germany HMOs Market Size 2026-2031 ($ millions)
Figure 66. France HMOs Market Size 2026-2031 ($ millions)
Figure 67. UK HMOs Market Size 2026-2031 ($ millions)
Figure 68. Italy HMOs Market Size 2026-2031 ($ millions)
Figure 69. Russia HMOs Market Size 2026-2031 ($ millions)
Figure 70. Egypt HMOs Market Size 2026-2031 ($ millions)
Figure 71. South Africa HMOs Market Size 2026-2031 ($ millions)
Figure 72. Israel HMOs Market Size 2026-2031 ($ millions)
Figure 73. Turkey HMOs Market Size 2026-2031 ($ millions)
Figure 74. Global HMOs Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global HMOs Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries HMOs Market Size 2026-2031 ($ millions)